Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Moving the goal posts

Moving the goal posts

Date NI Event
10/22/07 (NI) FDA issues draft guidance noting concerns over NI designs and asks sponsors to re-evaluate all ongoing or completed non-inferiority studies intended to support approval of an

Read the full 409 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE